[Wiley] Reliable Performance of mALBI Grade©Based Risk Models for Predicting the Prognosis of Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab as First©Line Treatment: Comparative Analysis of 13 Risk Models

noona Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-08 15:45
Reward10points

journal£ºJournal of Gastroenterology and Hepatology

Authors£ºTakeshi Hatanaka; Satoru Kakizaki; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hidenori Toyoda; Chikara Ogawa; Hiroki Nishikawa; Takashi Nishimura; Kazuhito Kawata; Hisashi Kosaka; Atsushi Naganuma; Yutaka Yata; Hideko Ohama; Hidekatsu Kuroda; Tomomitsu Matono; Kazunari Tanaka; Fujimasa Tada; Kazuhiro Nouso; Asahiro Morishita; Akemi Tsutsui; Takuya Nagano; Norio Itokawa; Tomomi Okubo; Taeang Arai; Michitaka Imai; Yohei Koizumi; Shinichiro Nakamura; Masaki Kaibori; Hiroko Iijima; Yoichi Hiasa; Takashi Kumada;  

Published date£º2025-4-

DOI£º10.1111/jgh.16871

PDF link£ºhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jgh.16871

Article link£ºhttps://doi.org/10.1111/jgh.16871

Article Source£ºWiley¡£


Remark£º
Reply

Use magic Donate Report

All Reply1 Show all posts
AnjumKamran Post time 2 min. ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    600


Daily Top Contributors

Return to the list